Brevan Howard Capital Management »

Vanda Pharmaceuticals shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Vanda Pharmaceuticals (VNDA) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Vanda Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Vanda Pharmaceuticals held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vanda Pharmaceuticals by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $468k 53k 8.82
2024-06-30 $177k 31k 5.65
2024-03-31 $75k 18k 4.11
2023-12-31 $108k 26k 4.22

More positions owned by Brevan Howard Capital Management

Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
First Tr Exchange Traded Sm Cap Buywrite (FTKI)
Pdd Holdings Sponsored Ads Call Option (PDD)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Alphabet Cap Stk Cl A (GOOGL)
Bank of America Corporation Call Option (BAC)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores Call Option (WMT)
Select Sector Spdr Tr State Street Uti Call Option (XLU)

View all positions for Brevan Howard Capital Management

Top funds holding Vanda Pharmaceuticals

BlackRock
Vanguard Group
Renaissance Technologies
Acadian Asset Management
Dimensional Fund Advisors
AIGH Capital Management
Millennium Management
Geode Capital Management
State Street Corporation
Krensavage Asset Management
Empire Financial Management Company
Two Sigma Advisers
Two Sigma Investments
Connor, Clark & Lunn Investment Management
Jacobs Levy Equity Management

View all funds holding Vanda Pharmaceuticals